Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
Company Announcements
Medexus Pharmaceuticals Earnings Call: Cautious Optimism Amid Challenges
6d ago
Premium
Ratings
Buy Rating Affirmed for Medexus Pharmaceuticals Inc. Based on Solid Financial Performance and Strategic Positioning
24d ago
Premium
Company Announcements
Medexus Pharmaceuticals Reports Strong Q1 2026 Results Driven by GRAFAPEX Launch
25d ago
Premium
Pre-Earnings
Medexus Pharmaceuticals (MDP) Q1 Earnings Cheat Sheet
28d ago
Premium
Company Announcements
Medexus Pharmaceuticals Announces First Fiscal Quarter 2026 Conference Call
1M ago
Premium
Company Announcements
Medexus Pharmaceuticals’ GRAFAPEX™ Receives NTAP Approval for 2026
1M ago
Premium
Ratings
Positive Outlook for Medexus Pharmaceuticals: Buy Rating Affirmed by Analyst
2M ago
Premium
Company Announcements
Medexus Pharmaceuticals’ Earnings Call Highlights GRAFAPEX Success
2M ago
Premium
Company Announcements
Medexus Pharmaceuticals Reports Strong FY 2025 Results and Successful GRAFAPEX Launch
2M ago
Premium
Pre-Earnings
MDP Upcoming Earnings Report: What to Expect?
3M ago
Premium
Company Announcements
Medexus Pharmaceuticals Announces Fiscal Year 2025 Financial Results Conference Call
3M ago
Premium
Company Announcements
Medexus Secures Public Reimbursement for Trecondyv® in Quebec
5M ago
Premium
Company Announcements
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
5M ago
Premium
Company Announcements
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
6M ago
Premium
Company Announcements
Medexus Launches GRAFAPEX in US, Eyes $100M Revenue
6M ago
Premium
Ratings
Positive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable Performance
7M ago
Premium
Company Announcements
Medexus Pharmaceuticals: Robust Earnings Amidst Challenges
7M ago
Premium
Ratings
Medexus Pharmaceuticals Inc.: Balancing Growth Potential and Risks with a Hold Rating
7M ago
Premium
Company Announcements
Medexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
7M ago
Premium
Company Announcements
Medexus Secures Ontario Public Reimbursement for Trecondyv
7M ago
Premium
Pre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Premium
Company Announcements
Medexus Pharmaceuticals to Discuss Q3 2025 Results in Upcoming Conference Call
7M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
